Cancer Biomarkers Market is Estimated To Witness High Growth Owing To Early Cancer Detection Trends

The Cancer Biomarkers Market is estimated to be valued at US$ 380.84 Bn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Cancer biomarkers are biological molecules found in blood, urine or body … Read more

Market Is Estimated To Witness High Growth Owing To Increased Focus On Quality Assurance and Regulatory Approval

The Laboratory Proficiency Testing market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 – 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Laboratory proficiency testing refers to the process of evaluating the performance … Read more

Western Blotting Market Is Estimated To Witness High Growth Owing To Increasing Applications

The Western Blotting Market is estimated to be valued at US$ 759.5 million in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Clinical Diagnostic Market Offers High Growth Due to Growing Adoption Among Medical Professionals and Technological Advancements

The clinical diagnostic market is estimated to be valued at US$ 79.72 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Legionella Testing Market to Reach US$312.6 Million by 2023

The global Legionella Testing Market is estimated to be valued at US$312.6 million in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Legionella testing refers to the detection and identification of Legionella bacteria in water sources. … Read more

Genomic Cancer Testing Market is Estimated To Witness High Growth Owing To Technological Advancements and Increasing Incidence of Cancer

The Genomic Cancer Testing Market is estimated to be valued at US$16.15 billion in 2023 and is expected to exhibit a CAGR of 16.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Digital PCR and Real-time PCR (qPCR) have greatly evolved in recent years

The utilization of DNA profiling has created through the latest a few years with the happening to digital inspecting methods. The Digital Polymerase Chain Reaction (DPCR) and the Real-Time Polymerase Chain Reaction (RTP) are two notable DNA profiling procedures. DPCR methodology deals with single particles while the RTP procedure works on various strands of DNA … Read more